# Endocrine Agents: Diabetes – Non-Insulin

**AUTHORIZATIONS:**  365 Days

**PRIOR AUTHORIZATION CRITERIA:**

Is there any reason the patient cannot be changed to a medication within the same class not requiring prior approval?

Acceptable reasons include:

- Allergy to medications not requiring prior approval

- Contraindication to or drug interaction with medications not requiring prior approval

- History of unacceptable/toxic side effects to medications not requiring prior approval

**NON-PREFERRED:**

1. There must have been a therapeutic failure of at least 60-day trial and failure with three preferred products

   Note: Inadequate clinical response after at least 60 days of recommended therapeutic dose with documented adherence to the regimen.

| **DIABETES – ORAL HYPOGLYCEMICS, SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR AND DPP-4** **COMBINATIONS** | |
|----------------------------------|-----------------------------------------|
| **PREFERRED**                    | **NON-PREFERRED**                        |
| No less than **90 days** of at least **one** preferred DPP-4 and SGLT product  | GLYXAMBI (empagliflozin/ linagliptin) |
|                                  |  QTERN (dapaglifozin-saxagliptin)                                           |
|                                  |  STEGLUJAN™ (ertugliflozin/sitagliptin)                                     |

Soliqua and Xultophy Request must address inability to use the individual components.

## Diabetes - Non-Insulin

| Endocrine Agents: Diabetes – Non-Insulin  |                                     |
|-------------------------------------------|-------------------------------------|
| PREFERRED                                 | NON-PREFERRED                       |
| Acarbose                                  | Adlyxin                             |
| Actoplus Met XR                           | Alogliptin                          |
| Byetta                                    | Alogliptin/Metformin                |
| Farxiga                                   | Bydureon Bcise                      |
| Glimepiride                               | Glimepiride/Pioglitazone            |
| Glipizide                                 | Glucophage                          |
| Glipizide/Metformin                       | Glyxambi                            |
| Glyburide                                 | Invokamet XR                        |
| Glyburide/Metformin                       | Jentadueto XR                       |
| Invokamet                                 | Kombiglyze XR                       |
| Invokana                                  | Metformin ER (Generic of Fortamet)  |
| Janumet                                   | Metformin Sol                       |
| Janumet XR                                | Onglyza                             |
| Januvia                                   | Ozempic                             |
| Jardiance                                 | Pioglitazone/Alogliptin             |
| Jentadueto                                | Qtern                               |
| Metformin                                 | Rybelsus                            |
| Metformin ER (Generic of Glucophage XR)   | Segluromet                          |
| Miglitol                                  | Soliqua                             |
| Nateglinide                               | Steglatro                           |
| Pioglitazone                              | Steglujan                           |
| Pioglitazone/Metformin                    | Symlinpen                           |
| Repaglinide                               | Synjardy XR                         |
| Repaglinide/Metformin                     | Trijardy XR                         |
| Synjardy                                  | Xigduo XR                           |
| Tradjenta                                 | Xultophy                            |
| Trulicity                                 |                                     |
| Victoza                                   |                                     |

**Link to Criteria:** [Endocrine Agents: Diabetes - Non-Insulin](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=49)
